Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
about
MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical propertiesMT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cellsThe enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPsRegulation of matrix metalloproteinase expression by dynamic tensile strain in rat fibrochondrocytesHow matrix metalloproteinases regulate cell behaviorMembrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice.Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils.Matrix metalloproteinase control of capillary morphogenesis.Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfateTIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.Matrix metalloproteinases in tumor invasion: role for cell migration.Physiology and pathophysiology of matrix metalloproteases.Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinaseMatrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development.Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture.Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish.Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity.Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processesMatrix metalloproteinases as modulators of inflammation.Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein sheddingPlacental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy.MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancerMatrix metalloproteinases in intracerebral hemorrhage.Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes.New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.Membrane-type matrix metalloproteinases: key mediators of leukocyte function.Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4-MMP) in breast cancer cells.Inhibition of tumor necrosis factor-alpha-induced RANTES secretion by alkaline protease in A549 cells.The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes.MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17.Application of peptides containing the cleavage sequence of pro-TNFalpha in assessing TACE activity of whole cells.
P2860
Q24683414-B03A252D-879F-4069-8AE0-F3477BE07960Q24685496-A9F3BDD5-88AF-4C0B-A0A4-87101485BF2EQ28215674-6780295F-815A-4B10-A084-3E19A562B21BQ28575086-74DC4FA2-9BAE-44E1-97C6-E261ED6D9935Q29620360-DC9210AB-6642-48B0-A0C5-CD456BA914D4Q33828362-3A08C500-B76F-4599-8293-1FC9AE28C984Q33935969-097FE9E4-0A87-4241-82F0-D36CE0465FDEQ33941026-D3930C2E-B5DD-401B-8EA4-BBAA409E1881Q34002149-FA88433A-04BA-4650-829C-7AD0C0BDBE48Q34144797-B09E85A9-1A99-4A79-8F94-68291ADAF41FQ34287261-51D04BB5-F397-441B-A1F5-2D3A82ABB558Q34545340-8CC761EB-318A-4367-B9C1-E8837EF7FA10Q34657461-6FE040B4-0250-4781-9C60-FC793E8A3E91Q35007715-32E75D76-36FA-4486-9FA0-85030EEE6DA2Q35063432-FFF1D922-10A6-43DB-9EAF-9FD4F33D46E6Q35312025-D19A0CE2-10BF-4DE9-8655-D289621E86F9Q35581768-819C248C-CC56-46A6-BD14-43F6BC006482Q35893461-51B43AC8-B27E-445F-92AF-DA0953CD9E58Q35949978-70F666A8-2C2F-4E2A-8C8C-6000C1D9F6C1Q36278360-751AFB77-DB48-455B-A4BC-8A73094CFC05Q36369114-7FEECAD2-B203-4845-AACA-A5C6F518D3D8Q36369835-FC9A1A94-C666-4B4E-BEA8-94ACBDAC9A71Q36449536-DC26DC26-644F-4A67-A68C-531617ADE5C0Q36715904-BE09F332-0395-490A-BB8B-6D75E13F0EE6Q36804675-ADBBE6D6-F2A2-4F1C-806A-F852BBC0FC85Q36857921-6FBDDBA2-8A70-4D87-9299-D665D5C5B3BFQ37088968-9A7E9854-C483-41D6-A5C4-5B16E861658DQ37282893-63AE903E-FB98-4BD3-A99A-166C0FC7E5B7Q37478659-263C944C-170C-4457-96F7-A4C2E92B84F5Q37733211-0F1369AA-ACDD-49FE-94E4-754D9A73324EQ37820192-011CE1B5-79BB-4C77-AE6F-CF9201A55BC3Q38108503-843874FF-B1EC-4CF0-ADDA-99C5EEF809E9Q38364218-2A4FA6FE-3168-4FE0-8851-217A90E33B28Q38870841-F2EF2A91-1CF7-401D-9B76-A90E96F3E051Q40216249-DFE4AFA1-BAA6-4DA0-B51D-C5EBF00D494DQ40394686-B02EC86D-1617-43B4-9F22-A15106A2A46BQ40513100-0FC980A1-CE7B-4C63-82C4-FCC9C8FB495FQ40542662-F58A8239-5C8C-4562-83D9-D8E1CD402882Q40558602-968B83BD-752C-42FD-96B7-72F1AC2EE071Q40677184-D13D8B65-FC49-4CEA-8090-C23CFFB2F6E3
P2860
Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@ast
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@en
type
label
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@ast
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@en
prefLabel
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@ast
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@en
P2093
P2860
P356
P1476
Membrane type 4 matrix metallo ...... ut does not activate pro-MMP2.
@en
P2093
A Merryweather
J M Freije
W R English
X S Puente
P2860
P304
14046-14055
P356
10.1074/JBC.275.19.14046
P407
P577
2000-05-01T00:00:00Z